Literature DB >> 27886904

Mastocytosis and Anaphylaxis.

Anna Schuch1, Knut Brockow2.   

Abstract

This article updates current knowledge on epidemiology, risk factors, triggers, and management of anaphylaxis in patients with mastocytosis. Hyperactive mast cells and higher number of effector mast cells are speculated to facilitate anaphylaxis in this condition. In children, increased risk is limited to those with extensive skin involvement and high tryptase. In adults, manifestations of anaphylaxis are severe with high frequency of cardiovascular symptoms. Hymenoptera stings are the most common triggers for these reactions; however, idiopathic anaphylaxis and reactions to food or drugs occur. Patients with mastocytosis should be informed about risk of anaphylaxis and prescribing emergency self-medication and installing emergency preparedness before general anesthesia is considered. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Drug-induced anaphylaxis; Hymenoptera venom anaphylaxis; Mast cell activation syndrome; Mastocytosis; Risk factors; Triggers

Mesh:

Substances:

Year:  2016        PMID: 27886904     DOI: 10.1016/j.iac.2016.08.017

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  17 in total

Review 1.  Component Resolved Diagnosis in Hymenoptera Anaphylaxis.

Authors:  D Tomsitz; K Brockow
Journal:  Curr Allergy Asthma Rep       Date:  2017-06       Impact factor: 4.806

Review 2.  Anaphylaxis.

Authors:  Daniel LoVerde; Onyinye I Iweala; Ariana Eginli; Guha Krishnaswamy
Journal:  Chest       Date:  2017-08-08       Impact factor: 9.410

Review 3.  The pathophysiology of anaphylaxis.

Authors:  Laurent L Reber; Joseph D Hernandez; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2017-08       Impact factor: 10.793

Review 4.  Drugs and Vaccines Hypersensitivity in Children with Mastocytosis.

Authors:  Francesca Mori; Giuseppe Crisafulli; Annamaria Bianchi; Paolo Bottau; Silvia Caimmi; Fabrizio Franceschini; Lucia Liotti; Claudia Paglialunga; Francesca Saretta; Carlo Caffarelli
Journal:  J Clin Med       Date:  2022-06-01       Impact factor: 4.964

Review 5.  How to manage anaphylaxis in primary care.

Authors:  Alberto Alvarez-Perea; Luciana Kase Tanno; María L Baeza
Journal:  Clin Transl Allergy       Date:  2017-12-11       Impact factor: 5.871

Review 6.  Insights in Anaphylaxis and Clonal Mast Cell Disorders.

Authors:  David González-de-Olano; Iván Álvarez-Twose
Journal:  Front Immunol       Date:  2017-07-10       Impact factor: 7.561

7.  Drug-induced anaphylaxis in children.

Authors:  Fabio Cardinale; Doriana Amato; Maria Felicia Mastrototaro; Carlo Caffarelli; Giuseppe Crisafulli; Fabrizio Franceschini; Lucia Liotti; Silvia Caimmi; Paolo Bottau; Francesca Saretta; Francesca Mori; Roberto Bernardini
Journal:  Acta Biomed       Date:  2019-01-30

8.  Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis.

Authors:  Anne Lise Ferrara; Fabiana Piscitelli; Angelica Petraroli; Roberta Parente; Maria Rosaria Galdiero; Gilda Varricchi; Giancarlo Marone; Massimo Triggiani; Vincenzo Di Marzo; Stefania Loffredo
Journal:  J Immunol Res       Date:  2019-07-01       Impact factor: 4.818

Review 9.  Clinical Utility of Rush Venom Immunotherapy: Current Status.

Authors:  Vianney Gruzelle; Claire Mailhol; David W Waters; Laurent Guilleminault
Journal:  J Asthma Allergy       Date:  2020-01-07

10.  Vascular endothelial growth factors and angiopoietins as new players in mastocytosis.

Authors:  Simone Marcella; Angelica Petraroli; Mariantonia Braile; Roberta Parente; Anne Lise Ferrara; Maria Rosaria Galdiero; Luca Modestino; Leonardo Cristinziano; Francesca Wanda Rossi; Gilda Varricchi; Massimo Triggiani; Amato de Paulis; Giuseppe Spadaro; Stefania Loffredo
Journal:  Clin Exp Med       Date:  2021-03-09       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.